Peer Review Discovery in Bextra/Celebrex Litigation

Pharmalot has the editorial from Science. For a view on the other side (i.e., not panicked at the prospect of discovery into peer review), see my Nebraska Law Review article from last year. The SSRN draft is here

–BC